Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T16:26:48.904Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical utility of CERAD neuropsychological battery in elderly Jamaicans

Published online by Cambridge University Press:  01 March 1999

FREDERICK W. UNVERZAGT ,
OWEN S. MORGAN ,
CHARLES H. THESIGER ,
DENISE A. ELDEMIRE ,
JOHN LUSEKO ,
SARADA POKURI ,
SIU L. HUI ,
KATHLEEN S. HALL  and
HUGH C. HENDRIE
FREDERICK W. UNVERZAGT
Affiliation:
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN.
OWEN S. MORGAN
Affiliation:
Department of Medicine, University of the West Indies, Kingston, Jamaica.
CHARLES H. THESIGER
Affiliation:
Department of Psychiatry, University of the West Indies, Kingston, Jamaica.
DENISE A. ELDEMIRE
Affiliation:
Department of Community Health, University of the West Indies, Kingston, Jamaica.
JOHN LUSEKO
Affiliation:
Department of Medicine, University of the West Indies, Kingston, Jamaica.
SARADA POKURI
Affiliation:
Department of Psychiatry, University of the West Indies, Kingston, Jamaica.
SIU L. HUI
Affiliation:
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
KATHLEEN S. HALL
Affiliation:
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN.
HUGH C. HENDRIE
Affiliation:
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN.
Get access Rights & Permissions [Opens in a new window]

Abstract

Information on the clinical utility of neuropsychological tests in non-North-American samples is limited. We examined the diagnostic efficacy of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery in Jamaican men and women age 65 and older. A total of 72 elders were diagnosed as normal and 12 were demented based on history, physical, and neurological examination. Independent of this medical examination, participants were tested with the CERAD battery. Normal controls scored significantly better than dementia patients on all tests in the CERAD battery. A discriminant function found that a combination of Word List Learning Sum Recall and Boston Naming Test correctly classified a total of 81% of the cases (83% of the dements and 81% of the normal controls). This study is the first to demonstrate the clinical utility of the CERAD neuropsychological battery in the differential diagnosis of memory disorders of the aged in a non-North-American sample. (JINS, 1999, 5, 255–259.)

Keywords

Neuropsychological testsGeriatricsDementiaAlzheimer's diseaseDiagnosis
Type
BRIEF COMMUNICATION
Information
Journal of the International Neuropsychological Society , Volume 5 , Issue 3 , March 1999 , pp. 255 - 259
Copyright
© 1999 The International Neuropsychological Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)